6KRO image
Deposition Date 2019-08-22
Release Date 2020-04-01
Last Version Date 2024-03-27
Entry Detail
PDB ID:
6KRO
Title:
Tankyrase-2 in complex with RK-582
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tankyrase-2
Gene (Uniprot):TNKS2
Chain IDs:A
Chain Length:168
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Tankyrase-2
Gene (Uniprot):TNKS2
Chain IDs:B
Chain Length:48
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer.
J.Med.Chem. 63 4183 4204 (2020)
PMID: 32202790 DOI: 10.1021/acs.jmedchem.0c00045

Abstact

Tankyrases (TNKS/TNKS2) belong to the poly(ADP-ribose) polymerase family. Inhibition of their enzymatic activities attenuates the Wnt/β-catenin signaling, which plays an important role in cancer pathogenesis. We previously reported the discovery of RK-287107, a spiroindoline-based, highly selective, potent tankyrase inhibitor. Herein we describe the optimization process of RK-287107 leading to RK-582, which exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered. In addition to the dose-dependent elevation and attenuation of the levels of biomarkers AXIN2 and β-catenin, respectively, results of the TCF reporter and cell proliferation studies on COLO-320DM are discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures